Coughzip BR Syrup
By Coughzip BR
Rx
100ml Syrup in a Bottle

Composition
Ambroxol(15mg/5ml) + Guaifenesin(50mg/5ml) + Menthol(2.5mg/5ml) + Terbutaline(1.25mg/5ml)

Manufacturer - Biovensia Pharmaceutical
Roma House, C/O Biovensia, Roma Pharma pvt. ltd, The Mall, Solan (H.P.)

Expires on or after
October, 2025

liver
Coughzip BR Syrup is considered safe for use in individuals with liver disease. Based on the limited data available, it appears that there may not be a need for dose adjustment of Coughzip BR Syrup in patients with liver issues. It is advisable to seek guidance from your doctor before using this syrup, especially if you have concerns regarding your liver health.

kidney
Coughzip BR Syrup is likely safe for use in patients with kidney disease. Available data indicates that adjusting the dose may not be necessary. Consult your doctor for guidance.

alcohol
Consult your doctor when consuming alcohol with Coughzip BR Syrup.

driving
It is not clear if Coughzip BR Syrup affects driving ability. Refrain from driving if you have symptoms that disrupt focus and reaction times.

pregnancy
Coughzip BR Syrup is not recommended during pregnancy due to limited human studies, but animal studies suggest harm to the baby. Consult your doctor for a full evaluation of benefits and risks before using.

breastfeeding
It is better to consult your doctor before using Coughzip BR Syrup during breastfeeding.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹80
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024